Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes

In summary, over the past 16 years, since the publication of Kelly West's book, epidemiological study has provided better insight into the relation of hyperglycemia and diabetic complications. Data from the WESDR demonstrate a strong consistent relationship between hyperglycemia and the incidence and progression of microvascular (diabetic retinopathy, loss of vision, and nephropathy) and macrovascular (amputation and cardiovascular disease mortality) complications in people with IDDM and NIDDM (Figs. 19 and 20). The DCCT has demonstrated that intensive insulin therapy will reduce the incidence and progression of microvascular complications in people with IDDM (22). A number of further challenges await laboratory scientists and epidemiologists regarding hyperglycemia in people with diabetes. There is a need to understand the relation of hyperglycemia to pathogenetic mechanisms that lead to the development of specific complications, to develop new methods to detect and physiologically treat hyperglycemia, and to develop better methods of primary and secondary prevention of diabetic complications in people with IDDM and NIDDM.

[1]  [Histological aspects of diabetic retinopathy]. , 1961, Bulletin de la Societe belge d'ophtalmologie.

[2]  N. Woolf.  Diabetes and atherosclerosis. , 1971, Acta diabetologica latina.

[3]  P. McNamara,et al.  Morbidity and Mortality in Diabetics In the Framingham Population: Sixteen Year Follow-up Study , 1974, Diabetes.

[4]  S. Nelson,et al.  Relationship of Microvascular Disease in Diabetes to Metabolic Control , 1977, Diabetes.

[5]  K. M. West.  Epidemiology of diabetes and its macrovascular complications. , 1979, Diabetes care.

[6]  J. P. Moulin,et al.  ABNORMALITIES OF ERYTHROCYTE DEFORMABILITY AND PLATELET AGGREGATION IN INSULIN-DEPENDENT DIABETICS CORRECTED BY INSULIN IN VIVO AND IN VITRO , 1982, The Lancet.

[7]  Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report. , 1982, Diabetes.

[8]  H. Parving,et al.  EARLY AGGRESSIVE ANTIHYPERTENSIVE TREATMENT REDUCES RATE OF DECLINE IN KIDNEY FUNCTION IN DIABETIC NEPHROPATHY , 1983, The Lancet.

[9]  Kroccollaborativestudygroup.  Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial. , 1984, The New England journal of medicine.

[10]  D L DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. , 1984, Archives of ophthalmology.

[11]  D. DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. , 1984, Archives of ophthalmology.

[12]  H. Parving,et al.  Effects of Long‐term Antihypertensive Treatment on Kidney Function in Diabetic Nephropathy , 1985, Hypertension.

[13]  T. Deckert,et al.  Two-Year Experience with Continuous Subcutaneous Insulin Infusion in Relation to Retinopathy and Neuropathy , 1985, Diabetes.

[14]  Torsten Deckert,et al.  EFFECT OF TWO YEARS OF STRICT METABOLIC CONTROL ON PROGRESSION OF INCIPIENT NEPHROPATHY IN INSULIN-DEPENDENT DIABETES , 1986, The Lancet.

[15]  J. Wetzels,et al.  The changing natural history of nephropathy in type I diabetes. , 1986, The American journal of medicine.

[16]  K. Dahl-Jørgensen,et al.  Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. , 1986, British medical journal.

[17]  L. Rand,et al.  Risk of Proliferative Diabetic Retinopathy in Juvenile-Onset Type I Diabetes: A 40-yr Follow-up Study , 1986, Diabetes Care.

[18]  L. Rand,et al.  Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. , 1987, The American journal of cardiology.

[19]  J. Mester,et al.  The progression of diabetic nephropathy in type I diabetics: relationship to metabolic control and blood pressure. , 1987, The Journal of diabetic complications.

[20]  R. Klein,et al.  Glycosylated hemoglobin in a population-based study of diabetes. , 1987, American journal of epidemiology.

[21]  T. Kern,et al.  Progression of Incipient Diabetic Retinopathy During Good Glycemic Control , 1987, Diabetes.

[22]  D L DeMets,et al.  Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. , 1988, JAMA.

[23]  W. Knowler,et al.  Lower-Extremity Amputations in NIDDM: 12-Yr Follow-Up Study in Pima Indians , 1988, Diabetes Care.

[24]  P. Wilson,et al.  Incidence of Diabetic Retinopathy and Relationship to Baseline Plasma Glucose and Blood Pressure , 1988, Diabetes Care.

[25]  H. Chase,et al.  Glucose control and the renal and retinal complications of insulin-dependent diabetes. , 1989, JAMA.

[26]  D L DeMets,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. , 1989, Archives of ophthalmology.

[27]  D L DeMets,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. , 1989, Archives of ophthalmology.

[28]  D. DeMets,et al.  Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? , 1989, Archives of internal medicine.

[29]  UK Prospective Diabetes Study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. , 1990, Diabetes research.

[30]  R. Klein,et al.  The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathy. , 1991, American journal of epidemiology.

[31]  R. Klein,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. , 1991, Ophthalmology.

[32]  R. Klein,et al.  Cause-specific mortality in a population-based study of diabetes. , 1991, American journal of public health.

[33]  Elisa Lee,et al.  Development of Proliferative Retinopathy in NIDDM: A Follow-up Study of American Indians in Oklahoma , 1992, Diabetes.

[34]  Jennifer S. Lee,et al.  Lower-Extremity Amputation: Incidence, Risk Factors, and Mortality in the Oklahoma Indian Diabetes Study , 1993, Diabetes.

[35]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[36]  T. Orchard.  From Diagnosis and Classification to Complications and Therapy: DCCT Part II? , 1994, Diabetes Care.

[37]  A Fournier,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1994, The New England journal of medicine.

[38]  R. Klein,et al.  The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. , 1994, Archives of ophthalmology.

[39]  R. Klein,et al.  A comparison of the study populations in the Diabetes Control and Complications Trial and the Wisconsin Epidemiologic Study of Diabetic Retinopathy. , 1995, Archives of internal medicine.